VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2020 | Drug and toxin-induced hyperkinesias

Angelo Antonini • 20 May 2020
EAN 2020
Movement Disorders Ephedrone
Biology

Angelo Antonini, MD, PhD, University of Padua, Padua, Italy, talks on drug and toxin-induced hyperkinesias. Prof. Antonini highlights hyperkinetic movements that can occur as a consequence of metal accumulation or viral infections. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Angelo Antonini

3:42
Continuous dopaminergic stimulation to prevent motor complications in Parkinson's disease
Angelo Antonini • 24 Sep 2021
2:58
Increasing mobility in patients with Parkinson’s disease during COVID-19
Angelo Antonini • 29 Mar 2022
2:35
Levodopa dose adjustment versus adjunctive therapy in Parkinson’s disease
Angelo Antonini • 26 Jun 2022
1:46
The clinical benefit of safinamide in treating Parkinson’s disease
Angelo Antonini • 29 Mar 2022

Related Videos

5:22
Regenerative medicine-based approaches in Parkinson’s disease
Alfonso Fasano • 19 Oct 2023
7:21
Recent developments in cell replacement therapy for Parkinson’s disease
Alfonso Fasano • 19 Oct 2023
1:12
Functional electrical stimulation: beyond stroke
Rosalyn Grabarz • 12 Oct 2023
2:08
The future of neuromodulation in movement disorders
Alfonso Fasano • 7 Sep 2023
The content of VJNeurology is intended for healthcare professionals